Partnership provides innovative microscopy and image analysis resources to high-potential life science researchers in two-year incubator program.
WHITE PLAINS, N.Y., June, 2022 /PRNewswire/ — ZEISS Microscopy announces a strategic partnership with LabCentral, a non-profit company founded in 2013 as a launchpad for promising biotech start-ups. ZEISS will provide access to key life science microscopy innovations for imaging and analysis solutions to researchers in LabCentral’s 225,000 sq. ft. footprint in Cambridge, Massachusetts, USA.
ZEISS will provide microscopy solutions to equip LabCentral’s researchers for routine cell culture assessment, automated high-resolution imaging of live cells and whole slide scanning of fixed cells and tissues. Advanced electron microscopy solutions including cryo-EM for assessment of intracellular ultra-resolution structures will also be available. In addition, ZEISS is enabling access to AI and deep learning backed image analysis solutions for increasing experimental time-to-results, enabling researchers to make faster decisions based on reproducible analyses of large datasets.
When researchers sign on with LabCentral, they will be provided bench space and immediate access to cutting edge technology, including ZEISS instrumentation. Partners like ZEISS enable the 125+ startups that rotate through LabCentral on an annual basis by providing access to equipment that typically is too time intensive and cost prohibitive to procure on their own. This is in addition to the additional business services provided by LabCentral, including purchasing and procurement, maintenance, IT, and security among other daily needs.
By investing in these visionary researchers, ZEISS, LabCentral and their partners remove the initial hurdles that biotech start-ups face, enabling them to focus on their research and speed up the realization of their visions – from personalized healthcare to drug discovery to new innovative improvements in human health.
About ZEISS
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 7.5 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2021).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With around 37,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 31 March 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
ZEISS Research Microscopy Solutions
ZEISS Research Microscopy Solutions is the world’s only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy. The portfolio comprises of products and services for life sciences, materials and industrial research, as well as education and clinical practice. The unit is headquartered in Jena. Additional production and development sites are located in Oberkochen and Munich, as well as in Cambourne (UK) and Dublin (USA). ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.
CONTACT:
Megan Gagliardi,
ZEISS Research Microscopy Solutions,
Tel. 914-216-2425,
E-Mail: megan.gagliardi@zeiss.com
